Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2.
暂无分享，去创建一个
T. Matsumura | T. Omasa | S. Enosawa | T. Miyashita | H. Tanaka | X. Li | S. Suzuki | H. Amemiya | K. Suga
[1] N. Sussman,et al. The Hepatix extracorporeal liver assist device: initial clinical experience. , 1994, Artificial organs.
[2] A. Demetriou,et al. Clinical Experience with a Porcine Hepatocyte-Based Liver Support System , 1996, The International journal of artificial organs.
[3] S. Enosawa,et al. Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. , 1996, Cell transplantation.
[4] R. Hauser,et al. Transplantation of testis-derived sertoli cells into the brain , 1996 .
[5] Experimental evaluation of a hybrid liver support system. , 1997, Transplantation proceedings.
[6] P. Sandstrom,et al. Xenotransplantation and the risk of retroviral zoonosis. , 1998, Trends in microbiology.
[7] T. Matsumura,et al. Long-Term Culture of Glutamine Synthetase-Transfected HepG2 Cells in Circulatory Flow Bioreactor for Development of a Bioartificial Liver , 2000, Cell transplantation.